Company intelligence / Profile preview
Capsida Biotherapeutics
Thousand Oaks, California, United Statescapsida.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Capsida is developing targeted gene therapies with high specificity and safety profiles, aiming to treat CNS disorders and other diseases.
- Therapeutic areas
- Rare DiseasesNeurology
- Modalities
- Gene replacementgene editinggene silencingvectorized antibodies
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
AbbVieCRISPR TherapeuticsPrevail Therapeutics (Eli Lilly)Kate Therapeutics
Beyond the preview
Go deeper on Capsida Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Capsida Biotherapeutics.